Kumar, Sandeep

Computational approaches to therapeutic antibody design: established methods and emerging trends

Norman, R. A., Ambrosetti, F., Bonvin, A. M. J. J., Colwell, L. J., Kelm, S., Kumar, S., & Krawczyk, K. (2020) · Briefings in Bioinformatics

Monoclonal and Polyclonal Antibodies Researchvaccines and immunoinformatics approaches

Cited by 219

Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies

Wang, X., Das, T. K., Singh, S. K., & Kumar, S. (2009) · mAbs

Protein purification and stabilityMonoclonal and Polyclonal Antibodies Research

Cited by 198

Coupling of aggregation and immunogenicity in biotherapeutics: T- and B-cell immune epitopes may contain aggregation-prone regions

Kumar, S., Singh, S. K., Wang, X., Rup, B., & Gill, D. (2011) · Pharmaceutical Research

Protein purification and stabilityvaccines and immunoinformatics approaches

Cited by 85

Potential aggregation-prone regions in complementarity-determining regions of antibodies and their contribution towards antigen recognition: a computational analysis

Wang, X., Singh, S. K., & Kumar, S. (2010) · Pharmaceutical Research

Monoclonal and Polyclonal Antibodies ResearchProtein purification and stability

Cited by 79

Relationship between potential aggregation-prone regions and HLA-DR-binding T-cell immune epitopes: implications for rational design of novel and follow-on therapeutic antibodies

Kumar, S., Mitchell, M. A., Rup, B., & Singh, S. K. (2012) · Journal of Pharmaceutical Sciences

vaccines and immunoinformatics approachesMonoclonal and Polyclonal Antibodies Research

Cited by 33